The latest version of Abbott's FreeStyle Libre continuous glucose monitor is now available via the NHS to eligible people with diabetes in the UK. Abbott's wearable FreeStyle Libre 3 device – which is ...
That being said, even among dividend stocks, many aren't worth sticking with for the long term. Let's consider one dividend ...
On social media, Tandem Diabetes Care (Nasdaq:TNDM) said the launch of a new integration for its insulin pump system is near.
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Global equity markets continued ...
Medshield Medical Scheme launched its benefit options and contributions for 2026, building on its Partner for Life offering with a strong member-centric theme of Predict and Prevent.
Abbott continues to get a boost in its Medical Devices business from its Diabetes unit's portfolio of continuous glucose ...
WeightWatchers for Business Annual Report Shows Breakthrough Weight Loss Results and Health Outcomes
(NASDAQ: WW) (“WeightWatchers” or the “Company”), the global leader in science-backed weight management, today published its 2025 Annual Report from WeightWatchers for Business, offering a ...
The Trends in Travel™. The annual global report highlights shifts in traveller behavior and the destinations set to dominate ...
Medshield, already one of SA’s most financially stable open medical aid schemes, has set a high bar for the rest of the industry.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback